Skip to main content

Table 2 Liver function tests in rats fed standard and high-fat, cholesterol-rich diets with and without camel milk treatment for 8 weeks

From: Camel milk ameliorates steatohepatitis, insulin resistance and lipid peroxidation in experimental non-alcoholic fatty liver disease

 

Control (n=10)

CCM (n=20)

Ch (n=20)

Ch M (n=20)

F value P value

AST (U/L)

45.99 ± 2.47

48.16 ± 3.08 §

57.41 ± 3.18 †‡

50.91±4.18†‡§

35.49

<0.001

ALT (U/L)

52.43 ± 2.69

54.76 ± 4.18 §

70.77 ± 4.19 †‡

56.68±3.90†‡§

79.84

<0.001

AP (U/L)

85.39 ± 6.44

83.79 ± 6.36 §

116.33 ± 6.79 †‡

104.80 ±6.12†‡§

105.86

<0.001

GAMA-GT (U/L)

43.47 ± 8.19

44.14 ± 6.67 §

50.12 ±5.45 †‡

45.74 ±3.95 †§

4.46

0.006

Total bilirubin (mg/dl)

1.45 ± 0.23

1.28 ± 0.19 §

2.07 ± 0.44 †‡

1.23 ± 0.14 †§

36.70

<0.001

Direct bilirubin (mg/dl)

0.43 ± 0.08

0.49 ± 0.11§

0.82 ± 0.10 †‡

0.46 ± 0.08 †§

61.65

<0.001

Total proteins (mg/dl)

4.6 ± 0.19

6.25 ± 0.23 †‡

4.17 ± 0.15 †‡

5.05 ± 0.41 †‡§

199.68

<0.001

Serum albumin (mg/dl)

3.45 ± 0.05

3.85 ± 0.40 †§

3.15 ± 0.09 †‡

3.57 ± 0.28 †‡§

23.31

<0.001

  1. CCM; control + milk group, Ch; cholesterol group, ChM; cholesterol + milk group. Values are presented as the mean ± SD. Significant differences between all groups were identified by ANOVA test presented by F value. When significant (p value < 0.05), a post hoc LSD test was performed to compare the groups. † p < 0.05 versus control, ‡ p < 0.05 versus CCM, § p < 0.05 versus Ch, ¶ p < 0.05 versus ChM.